Group One Trading
PPBT

Group One Trading’s Purple Biotech PPBT Stock Holding History

Group One Trading’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250
Closed -$1.64K – 8497
2025
Q4 		$1.64K Buy
+250
New +$1.81K ﹤0.01% 7611
2025
Q1 		– Sell
-3,440
Closed -$161K – 8213
2024
Q4 		$161K Buy
+3,440
New +$132K ﹤0.01% 4104
2022
Q4 		– Sell
-25
Closed -$10K – 7904
2022
Q3 		$10K Sell
25
-11
-31% -$5.14K ﹤0.01% 6507
2022
Q2 		$17K Sell
36
-2
-5% -$1.2K ﹤0.01% 6415
2022
Q1 		$30K Buy
38
+19
+100% +$12.3K ﹤0.01% 6476
2021
Q4 		$14K Buy
19
+6
+46% +$5.11K ﹤0.01% 7185
2021
Q3 		$12K Hold
13
– – ﹤0.01% 7428
2021
Q2 		$12K Buy
+13
New +$11.9K ﹤0.01% 7457

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Group One Trading's PPBT Position: Q2 2026 in Review

Group One Trading sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 20 shares — an estimated $67 sold.

Group One Trading first reported a position in PPBT in Q1 2021 and held it in 18 quarters. The position peaked at $214K in Q3 2021. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Group One Trading reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 20 Purple Biotech shares in Q2 2026, an estimated $67.
  • Group One Trading first reported a position in Purple Biotech in Q1 2021 and held it in 18 quarters.
  • Group One Trading's Purple Biotech position peaked at $214K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.